Nonlymphoid cells interacted with mitogens fail to elaborate macrophage migration inhibitory factor (MIF).

[1]  E. Pick,et al.  A simple method for the production of migration inhibitory factor by concanavalin A - stimulated lymphocytes. , 1977, Journal of immunological methods.

[2]  T. Yoshida,et al.  Lymphokine-like factors produced by human lymphoid cell lines with B or T cell surface markers. , 1976, Journal of immunology.

[3]  P. Kaplowitz,et al.  Lectin-mediated stimulation of DNA synthesis in cultures of embryonic neural retina cells. , 1976, Experimental cell research.

[4]  J. David,et al.  Partial characterization of murine migration inhibitory factor (MIF). , 1976, Journal of immunology.

[5]  M. M. Taylor,et al.  Problems encountered in the preparation of migration inhibitory factor (MIF) and mitogenic factor (MIT) from phytomitogen-stimulated human peripheral lymphocytes and in the preparation of MIF from human lymphoid cell lines (LCL). , 1975, Cellular immunology.

[6]  G. Poste.  Production of a serine-protease with macrophage migration-inhibitory factor activity by virus-transformed cells and human tumor cell lines. , 1975, Cancer research.

[7]  E. Pick,et al.  Participation of immunoglobulin‐bearing lymphocytes in the production of macrophage migration inhibitory factor , 1975, European journal of immunology.

[8]  U. Persson,et al.  Effect of Polyclonal B‐Cell Activators on DNA Synthesis in Fibroblasts , 1975, Scandinavian journal of immunology.

[9]  T. Yoshida,et al.  Production of lymphokine-like factors (cytokines) by simian virus 40-infected and simian virus 40-transformed cells. , 1975, The American journal of pathology.

[10]  C. O'neill,et al.  Stimulation of the proliferation of normal BHK21 cultured fibroblasts by plant lectins. , 1975, Experimental Cell Research.

[11]  G. Poste.  Production of macrophage migration inhibitory factor(s) (MIF) by virus-transformed cells☆ , 1975 .

[12]  D. Belpomme,et al.  Production of migration inhibition factor (MIF) by human established B type cell lines derived from normal and malignant tissues: studies of some factors affecting MIF release. , 1975, Cellular immunology.

[13]  R. Macdermott,et al.  STUDIES ON MEDIATOR PRODUCTION BY HIGHLY PURIFIED HUMAN T AND B LYMPHOCYTES , 1974, The Journal of experimental medicine.

[14]  H. Dvorak,et al.  MIF-Like Activity in Simian Virus 40-Transformed 3T3 Fibroblast Cultures , 1974, Science.

[15]  L. Ossowski,et al.  Fibrinolysis associated with oncogenic transformation. Morphological correlates. , 1974, The Journal of biological chemistry.

[16]  P. Papageorgiou,et al.  Migration inhibitory factor (MIF) production by skin fibroblast cultures from patients with severe combined immunodeficiency. , 1974, Cellular immunology.

[17]  M. Sarvas,et al.  MITOGENIC EFFECT BY LIPOPOLYSACCHARIDE AND POKEWEED LECTIN ON DENSITY-INHIBITED CHICK EMBRYO FIBROBLASTS , 1973, The Journal of experimental medicine.

[18]  T. Yoshida,et al.  THE PRODUCTION OF MIGRATION INHIBITION FACTOR BY B AND T CELLS OF THE GUINEA PIG , 1973, The Journal of experimental medicine.

[19]  T. Yoshida,et al.  Production of Macrophage Migration Inhibition Factors by Virus-Infected Cell Cultures , 1973, Infection and immunity.

[20]  E. Pick,et al.  The mechanism of action of soluble lymphocytic mediators. I. A pulse exposure test for the measurement of macrophage migration inhibitory factor. , 1973, Immunology.

[21]  G. Biberfeld.  Macrophage migration inhibition in response to experimental mycoplasma pneumoniae infection in the hamster , 1973, The Journal of Immunology.

[22]  M. Libich.  Incorporation of amino acid analogues into proteins of live mammalian cells and change of antigenic specificity of cell antigens demonstrated by migration inhibition test. , 1972, Immunology.

[23]  A. Bloom,et al.  Synthesis of macrophage migration inhibition factor (MIF) by immunoglobulin-producing lymphocyte lines and their clones. , 1972, Journal of immunology.

[24]  P. Ward,et al.  LEUKOTACTIC FACTORS ELABORATED BY VIRUS-INFECTED TISSUES , 1972, The Journal of experimental medicine.

[25]  J. Kaplan.  Staphylococcal enterotoxin B induced release of macrophage migration inhibition factor from normal lymphocytes. , 1972, Cellular immunology.

[26]  P. Papageorgiou,et al.  Production and characterization of migration inhibitory factor(s) (MIF) of established lymphoid and non-lymphoid cell lines. , 1972, Journal of immunology.

[27]  R. Lerner,et al.  PRODUCTION OF MACROPHAGE MIGRATION INHIBITION FACTOR BY CONTINUOUS CELL LINES , 1972, The Journal of experimental medicine.

[28]  P. Vassalli,et al.  Inhibition of Macrophage Migration by a Soluble Factor from Lymphocytes stimulated with PHA or ALS , 1971, Nature.

[29]  J. White,et al.  Production of lymphotoxin and migration inhibitory factor by established human lymphocytic cell lines. , 1970, Journal of immunology.

[30]  J. Brostoff,et al.  Interaction between "sensitized lymphocytes" and antigen in vitro. II. Mitogen-induced release of skin reactive and macrophage migration inhibitory factors. , 1970, Cellular immunology.

[31]  A. Yaniv,et al.  Factors associated with spontaneous transformation of hamster cells in culture. , 1970, Journal of the National Cancer Institute.

[32]  B. Bloom,et al.  Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity , 1966, Science.

[33]  J. David.  SUPPRESSION OF DELAYED HYPERSENSITIVITY IN VITRO BY INHIBITION OF PROTEIN SYNTHESIS , 1965, The Journal of experimental medicine.

[34]  I. Macpherson,et al.  Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence. , 1962, Virology.

[35]  H. Eagle,et al.  Amino acid metabolism in mammalian cell cultures. , 1959, Science.